Structures by: Rong H.

Total: 23

Nitrendipine

C18H20N2O6

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=8.82590(10)Å   b=15.2013(2)Å   c=12.94740(10)Å

α=90°   β=93.7770(10)°   γ=90°

Axitinib

2(C22H18N4OS)

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=11.8120(2)Å   b=12.3827(2)Å   c=14.7603(2)Å

α=80.868(2)°   β=81.207(2)°   γ=65.701(2)°

Clotrimazole

C22H17ClN2

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=8.68460(10)Å   b=10.3809(2)Å   c=10.5107(2)Å

α=113.566(2)°   β=97.7510(10)°   γ=96.7670(10)°

Nifedipine

C17H18N2O6

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=10.6219(4)Å   b=10.4085(4)Å   c=14.7800(5)Å

α=90°   β=94.879(3)°   γ=90°

Repaglinide

C27H36N2O4

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=8.32210(10)Å   b=13.3053(2)Å   c=22.7527(3)Å

α=90°   β=90°   γ=90°

Ciclopirox

C12H17NO2

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=25.3104(4)Å   b=27.6509(4)Å   c=19.1485(2)Å

α=90°   β=96.1260(10)°   γ=90°

Nimodipine

C21H26N2O7

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=13.76260(10)Å   b=10.72760(10)Å   c=14.78350(10)Å

α=90°   β=104.3000(10)°   γ=90°

Vildagliptin

C17H25N3O2

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=10.14270(10)Å   b=10.60440(10)Å   c=14.51410(10)Å

α=90°   β=90°   γ=90°

Metformin

Cl,C4H11N5

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=7.9234(2)Å   b=13.8743(2)Å   c=7.9286(2)Å

α=90°   β=114.547(2)°   γ=90°

Celecoxib

C17H14F3N3O2S

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=5.06400(10)Å   b=10.01390(10)Å   c=16.40730(10)Å

α=89.8820(10)°   β=85.8650(10)°   γ=80.5380(10)°

Indomethacin

C19H16ClNO4

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=9.21730(10)Å   b=9.6060(2)Å   c=10.8436(2)Å

α=69.959(2)°   β=87.1970(10)°   γ=69.501(2)°

Aspirin

C9H8O4

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=11.2582(3)Å   b=6.54710(10)Å   c=11.2600(3)Å

α=90°   β=95.949(2)°   γ=90°

Fluconazole

C13H12F2N6O

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=12.9345(2)Å   b=6.02210(10)Å   c=34.8527(8)Å

α=90°   β=90°   γ=90°

Paracetamol

C8H9NO2

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=7.08950(10)Å   b=9.21120(10)Å   c=11.59660(10)Å

α=90°   β=97.8900(10)°   γ=90°

Gliclazide

C15H21N3O3S

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=10.63520(10)Å   b=14.32960(10)Å   c=10.89950(10)Å

α=90°   β=106.6230(10)°   γ=90°

Felodipine

C18H19Cl2NO4

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=12.0936(2)Å   b=12.0624(2)Å   c=13.4258(2)Å

α=90°   β=116.167(2)°   γ=90°

Griseofulvin

C17H17ClO6

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=11.6345(2)Å   b=12.0011(3)Å   c=23.8695(5)Å

α=90°   β=90°   γ=90°

Lorlatinib

C21H19FN6O2

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=13.16690(10)Å   b=15.49550(10)Å   c=18.85980(10)Å

α=90°   β=90°   γ=90°

Gefitinib

C22H24ClFN4O3

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=8.81100(10)Å   b=9.6610(2)Å   c=12.4893(2)Å

α=93.6600(10)°   β=97.5860(10)°   γ=101.8710(10)°

Crizotinib

C21H22Cl2FN5O

Ou, XiaoLi, XizhenRong, HaoweiYu, LianLu, Ming

Chemical communications (Cambridge, England) (2020) 56, 69 9950-9953

a=15.2412(4)Å   b=10.1051(3)Å   c=14.0138(4)Å

α=90°   β=100.491(3)°   γ=90°

Zangboite

FeSi2Ti

Li, G.Fang, Q.Shi, N.Bai, W.Yang, J.Xiong, M.Ma, Z.Rong, H.

The Canadian Mineralogist (2009) 47, 1265-1274

a=8.6053Å   b=9.5211Å   c=7.6436Å

α=90°   β=90°   γ=90°

Qusongite

CW

Fang, Q.Bai, W.Yang, J.Xu, X.Li, G.Shi, N.Xiong, M.Rong, H.

American Mineralogist (2009) 94, 387-290

a=2.902Å   b=2.902Å   c=2.831Å

α=90°   β=90°   γ=120°

Linzhiite

FeSi2

Li, G.Bai, W.Shi, N.Fang, Q.Xiong, M.Yang, J.Ma, Z.Rong, H.

European Journal of Mineralogy (2012) 24, 1047-1052

a=2.696Å   b=2.696Å   c=5.147Å

α=90°   β=90°   γ=90°